# US 2025/0327802 A1 · Methods of Evaluating Virus-Producing Cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0327802 A1
- Document ID: US20250327802A1
- Status: Published application
- Kind: A1
- Application number: 19/204,872
- Filed: 2025-05-12
- Published: 2025-10-23
- Earliest claimed: 2022-11-17
- Assignees: Bruker Cellular Analysis, Inc.
- Applicants: Bruker Cellular Analysis, Inc.
- Inventors: Jason C. Briggs; Leqian Liu; Nathan J. Ver Heul; Chen Sun; Eric Chun-Jen Shiue; Chih-Yun Hsia; Alexander J. Mastroianni; Eric K. Sackmann; Jason M. McEwen; Peyton Shieh; Qiong Gao; J. Tanner Nevill; Volker L.S. Kurz; Michelle R. Murphy; Kellen C. Mobilia; Brittany R. Benlian; Lauren Ashley Washburn
- Web page: https://patentgrep.com/patent/US20250327802A1

## CPC

- G01N 33/56983: {Viruses}
- B01L 3/502761: {specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules}
- C12N 15/86: Viral vectors
- B01L 2200/0647: Handling flowable solids, e.g. microscopic beads, cells, particles
- B01L 2300/042: Caps; Plugs
- B01L 2300/12: Specific details about materials
- B01L 2400/0409: centrifugal forces
- B01L 2400/0424: Dielectrophoretic forces
- B01L 2400/0457: passive flow or gravitation
- C12N 2750/14143: viral genome or elements thereof as genetic vector
- C12N 2750/14152: relating to complementing cells and packaging systems for producing virus or viral particles
- C12Q 1/70: involving virus or bacteriophage {(immunoassay for viruses G01N33/56983)}
- G01N 15/1433: using image recognition
- G01N 15/1434: Optical arrangements
- G01N 2015/1006: {for cytology}
- G01N 2015/144: {Imaging characterised by its optical setup}
- G01N 2333/015: Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Method of evaluating a virus-producing cell on a microfluidic device is described therein. The method comprises culturing the virus-producing cell thereby producing a viral particle in a chamber of the microfluidic device; and evaluating a productivity of the virus-producing cell in producing the viral particle. Additionally, method for preserving a subset of biological micro-objects within a microfluidic device is also described herein so that the subset of biological micro-objects can be protected from being affected by the assays performed on the microfluidic device.

## Claims

### Claim 1

A method for preserving a subset of biological micro-objects within a microfluidic device, the method comprising:
moving a first subset of a plurality of biological micro-objects disposed in a first chamber of a microfluidic device into a second chamber of the microfluidic device,
wherein the microfluidic device comprises a microfluidic circuit material defining a flow region and a plurality of chambers fluidically connected to the flow region, wherein the plurality of chambers comprises the first chamber and the second chamber;
designating one of the first chamber and the second chamber as a preserving chamber and the other as an assay chamber; and
forming a first in situ-generated cap within the preserving chamber, wherein the first in situ-generated cap comprises a porosity to selectively block passage of the biological micro-objects between the preserving chamber and the flow region.

### Claim 2 (depends on 1)

The method of claim 1, wherein before moving the first subset of the plurality of biological micro-objects, the method further comprises disposing a biological micro-object into the first chamber, and expanding the biological micro-object into the plurality of biological micro-objects.

### Claim 3 (depends on 1)

The method of claim 1, wherein moving the first subset of the plurality of biological micro-objects into the second chamber comprises:
selecting one or more biological micro-object(s) from the plurality of biological micro-objects in the first chamber;
moving the selected one or more biological micro-object(s) from the first chamber into the second chamber, thereby forming a first subset of the plurality of biological micro-objects in the second chamber.

### Claim 4 (depends on 1)

The method of claim 1, wherein moving the first subset of the plurality of biological micro-objects into the second chamber comprises: moving one or more biological micro-object(s) from the first chamber into a transit area within the flow region and from the transit area into the second chamber, wherein the transit area is substantially enclosed by an in situ-generated barrier, thereby preventing the one or more biological micro-object(s) from entering an area of the flow region other than the transit area while allowing the one or more micro-object(s) to access the transit area, the first chamber, and the second chamber.

### Claim 5 (depends on 4)

The method of claim 4, further comprising removing the in situ-generated barrier after moving the first subset of the plurality of micro-objects into the second chamber.

### Claim 6 (depends on 1)

The method of claim 1, wherein moving the first subset of the plurality of biological micro-objects into the second chamber comprises using dielectrophoresis (DEP) force, gravity, centrifugation, or a combination thereof.

### Claim 7 (depends on 1)

The method of claim 1, wherein the plurality of biological micro-objects is a clonal population.

### Claim 8 (depends on 7)

The method of claim 7, wherein moving a first subset of the plurality of biological micro-objects into the second chamber further comprises retaining a second subset of the plurality of biological micro-objects in the first chamber, wherein the first subset and the second subset of biological micro-objects belong to the same clonal population.

### Claim 9 (depends on 8)

The method of claim 8, further comprising culturing the first subset of the plurality of biological micro-objects in the second chamber and culturing the second subset of the plurality of micro-objects in the first chamber.

### Claim 10 (depends on 1)

The method of claim 1, further comprising performing an assay in the assay chamber.

### Claim 11 (depends on 10)

The method of claim 10, wherein the assay is performed after forming the first in situ-generated cap, and wherein the first in situ-generated cap within the preserving chamber prevents the assaying from being performed within the preserving chamber.

### Claim 12 (depends on 10)

The method of claim 10, wherein performing an assay in the assay chamber comprises: allowing the first subset of the plurality of biological micro-objects and/or the second subset of the plurality of biological micro-objects to produce a biological product of interest.

### Claim 13 (depends on 12)

The method of claim 12, wherein performing an assay in the assay chamber further comprises assaying the biological product of interest.

### Claim 14 (depends on 10)

The method of claim 10, wherein performing an assay in the assay chamber comprises:
introducing a lysis buffer into the flow region of the microfluidic device;
diffusing the lysis buffer into the assay chamber; and
blocking the lysis buffer from entering the preserving chamber with the first in situ-generated cap.

### Claim 15 (depends on 1)

The method of claim 1, wherein the first in situ-generated cap is moveably connected to one or more surface of the preserving chamber, and/or wherein the first in situ-generated cap comprises a non-uniform thickness with respect to an axis of the chamber such that a portion of the in situ-generated cap is less thick than other portions thereof.

### Claim 16 (depends on 1)

The method of claim 1, wherein the first in situ-generated cap comprises a solidified polymer network.

### Claim 17 (depends on 16)

The method of claim 16, wherein the solidified polymer network comprises a synthetic polymer, a modified synthetic polymer, a biological polymer, or any combination thereof.

### Claim 18 (depends on 16)

The method of claim 16, wherein the solidified polymer network is reversible.

### Claim 19

A method of evaluating a virus-producing cell within a microfluidic device, the method comprising:
culturing the virus-producing cell in a chamber of the microfluidic device, wherein the microfluidic device comprises a microfluidic circuit material defining a flow region and a chamber, wherein the chamber opens to, and is fluidically connected to, the flow region;
allowing the virus-producing cell to produce a viral particle; and
evaluating a productivity of the virus-producing cell in producing the viral particle, wherein a cell genetically identical to the virus-producing cell, is preserved on the microfluidic device, in a region other than the flow region or the chamber, while evaluating the productivity of the virus-producing cell.

### Claim at position 20

-50. (canceled)

### Claim 51

A method of evaluating a virus-producing cell within a microfluidic device, the method comprising:
disposing the virus-producing cell in a first chamber of the microfluidic device and expanding the virus-producing cell into a plurality of virus-producing cells, moving a first subset of the plurality of virus-producing cells disposed in the first chamber of a microfluidic device into a second chamber of the microfluidic device,
wherein the microfluidic device comprises a microfluidic circuit material defining a flow region and a plurality of chambers fluidically connected to the flow region, wherein the plurality of chambers comprise the first chamber and the second chamber;
designating one of the first chamber and the second chamber as a preserving chamber and the other as an assay chamber; and
forming a first in situ-generated cap within the preserving chamber, wherein the first in situ-generated cap comprises a porosity to selectively block passage of the virus-producing cell between the preserving chamber and the flow region,
allowing the subset of the plurality of virus-producing cells in the assay chamber to produce a plurality of viral particles; and
evaluating a productivity of the virus-producing cell in producing the viral particle.
